122
Views
30
CrossRef citations to date
0
Altmetric
Review

Design and application of oncolytic HSV vectors for glioblastoma therapy

, , , , &
Pages 505-517 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Alice Giotta Lucifero & Sabino Luzzi. (2022) Emerging immune-based technologies for high-grade gliomas. Expert Review of Anticancer Therapy 22:9, pages 957-980.
Read now
Sara A. Collins, Ashish H. Shah, Derek Ostertag, Noriyuki Kasahara & Douglas J. Jolly. (2021) Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer. Expert Opinion on Biological Therapy 21:9, pages 1199-1214.
Read now
Adam M. Swartz, Steven H. Shen, Miguel A. Salgado, Kendra L. Congdon & Luis Sanchez-Perez. (2018) Promising vaccines for treating glioblastoma. Expert Opinion on Biological Therapy 18:11, pages 1159-1170.
Read now
Hiroshi Nakashima, Tran Nguyen & Ennio Antonio Chiocca. (2015) Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy. Oncolytic Virotherapy 4, pages 183-191.
Read now
George P Atkinson, Susan E Nozell & Etty (Tika) N Benveniste. (2010) NF-κB and STAT3 signaling in glioma: targets for future therapies. Expert Review of Neurotherapeutics 10:4, pages 575-586.
Read now

Articles from other publishers (25)

Xianwang Wang, Yihua Shen, Xingxia Wan, Xiaoqing Hu, Wen-Qi Cai, Zijun Wu, Qiang Xin, Xiaoqing Liu, Jingang Gui, Hong-Yi Xin & Hong-Wu Xin. (2023) Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy. Journal of Translational Medicine 21:1.
Crossref
Junsheng Li, Wen Wang, Jia Wang, Yong Cao, Shuo Wang & Jizong Zhao. (2021) Viral Gene Therapy for Glioblastoma Multiforme: A Promising Hope for the Current Dilemma. Frontiers in Oncology 11.
Crossref
Chibawanye I. Ene, Juan Fueyo & Frederick F. Lang. (2021) Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations. Neurosurgical Focus 50:2, pages E6.
Crossref
Julius W. Kim, Katarzyna C. Pituch, Annie Xiao, Jacob S. Young, Wojciech K. Panek, Megan E. Muroski, Aida Rashidi, J. Robert Kane, Deepak Kanojia & Maciej S. Lesniak. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 211 227 .
Alberto Reale, Lorenzo Messa, Adriana Vitiello, Arianna Loregian & Giorgio Palù. (2017) 4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy. Journal of Cellular Physiology 232:10, pages 2641-2648.
Crossref
Sourav R. Choudhury, Eloise Hudry, Casey A. Maguire, Miguel Sena-Esteves, Xandra O. Breakefield & Paola Grandi. (2017) Viral vectors for therapy of neurologic diseases. Neuropharmacology 120, pages 63-80.
Crossref
J.W. Kim, J. Murphy, A.L. Chang, D.A. Spencer, J.R. Kane, D. Kanojia, A. Rashidi, J.S. Young & M.S. Lesniak. 2017. Mesenchymal Stromal Cells as Tumor Stromal Modulators. Mesenchymal Stromal Cells as Tumor Stromal Modulators 475 499 .
Maria-Carmela Speranza, Kazue Kasai & Sean E. Lawler. (2016) Preclinical Mouse Models for Analysis of the Therapeutic Potential of Engineered Oncolytic Herpes Viruses. ILAR Journal 57:1, pages 63-72.
Crossref
Dipongkor Saha, Robert L. Martuza & William T. CurryJr.Jr.. 2016. Neurotropic Viral Infections. Neurotropic Viral Infections 481 517 .
Anda-Alexandra Calinescu, Neha Kamran, Gregory Baker, Yohei Mineharu, Pedro Ricardo Lowenstein & Maria Graciela Castro. (2015) Overview of current immunotherapeutic strategies for glioma. Immunotherapy 7:10, pages 1073-1104.
Crossref
Wen Zhang, Keli Ge, Qian Zhao, Xiufen Zhuang, Zhenling Deng, Lingling Liu, Jie Li, Yu Zhang, Ying Dong, Youhui Zhang, Shuren Zhang & Binlei Liu. (2015) A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4. Oncotarget 6:24, pages 20345-20355.
Crossref
Lucia Mazzacurati, Marco Marzulli, Bonnie Reinhart, Yoshitaka Miyagawa, Hiroaki Uchida, William F Goins, Aofei Li, Balveen Kaur, Michael Caligiuri, Timothy Cripe, Nino Chiocca, Nduka Amankulor, Justus B Cohen, Joseph C Glorioso & Paola Grandi. (2015) Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV. Molecular Therapy 23:1, pages 99-107.
Crossref
Richard Lee Price & Ennio Antonio Chiocca. (2014) Evolution of Malignant Glioma Treatment. Neurosurgery 61:Supplement 1, pages 74-83.
Crossref
Aldo Pourchet, Matias E. Melendez, Anna Greco & Alberto L. Epstein. 2014. Viral Vector Approaches in Neurobiology and Brain Diseases. Viral Vector Approaches in Neurobiology and Brain Diseases 51 93 .
Kazuo Okemoto, Kazue Kasai, Benjamin Wagner, Amy Haseley, Hans Meisen, Chelsea Bolyard, Xiaokui Mo, Allison Wehr, Amy Lehman, Soledad Fernandez, Balveen Kaur & E. Antonio Chiocca. (2013) DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas. Clinical Cancer Research 19:21, pages 5952-5959.
Crossref
Kazue Kasai, Hiroshi Nakashima, Fang Liu, Samantha Kerr, Jiang Wang, Mitch Phelps, Philip M Potter, William B Goins, Soledad A Fernandez & E Antonio Chiocca. (2013) Toxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with Prodrugs. Molecular Therapy - Nucleic Acids 2, pages e113.
Crossref
NaTosha N. Gatson, E. Antonio Chiocca & Balveen Kaur. (2012) Anti-angiogenic gene therapy in the treatment of malignant gliomas. Neuroscience Letters 527:2, pages 62-70.
Crossref
Annette Sorensen, Robert J. Mairs, Lynne Braidwood, Craig Joyce, Joe Conner, Sally Pimlott, Moira Brown & Marie Boyd. (2012) In Vivo Evaluation of a Cancer Therapy Strategy Combining HSV1716-Mediated Oncolysis with Gene Transfer and Targeted Radiotherapy. Journal of Nuclear Medicine 53:4, pages 647-654.
Crossref
Bonnie Reinhart, Lucia Mazzacurati, Adriana Forero, Chang-Sook Hong, Junichi Eguchi, Hideho Okada, Wendy Fellows, Ajay Niranjan, Justus B. Cohen, Joseph C. Glorioso & Paola Grandi. (2012) Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus. Advances in Virology 2012, pages 1-10.
Crossref
S L Longo, C Griffith, A Glass, E J Shillitoe & D E Post. (2010) Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter. Cancer Gene Therapy 18:2, pages 123-134.
Crossref
Marianela CandolfiWeidong XiongKader YagizChunyan LiuA. K. M. G. MuhammadMariana PuntelDavid FouladAli ZadmehrGabrielle E. AhlzadehKurt M. KroegerMatthew TesarfreundSharon LeeWaldemar DebinskiDhruv SareenClive N. SvendsenRon RodriguezPedro R. Lowenstein & Maria G. Castro. (2010) Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics. Proceedings of the National Academy of Sciences 107:46, pages 20021-20026.
Crossref
Ivy A.W. Ho, Kam M. Hui & Paula Y.P. Lam. (2010) Isolation of peptide ligands that interact specifically with human glioma cells. Peptides 31:4, pages 644-650.
Crossref
P C Huszthy, H Immervoll, J Wang, D Goplen, H Miletic, G E Eide & R Bjerkvig. (2009) Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment. Gene Therapy 17:2, pages 202-216.
Crossref
Hong Jiang & Juan Fueyo. 2010. Gene-Based Therapies for Cancer. Gene-Based Therapies for Cancer 17 32 .
Lawrence S. Kirschner. 2011. Adrenocortical Carcinoma. Adrenocortical Carcinoma 493 513 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.